Daratumumab Biosimilar - Research Grade

In stock

Only %1 left

SKU

ICH4020

Add to Compare

Be the first to review this product

$500.00

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Add to Wish List

Daratumumab Biosimilar - Research Grade

Product Benefits:

ichorbio’s Daratumumab Biosimilar - Research Grade is for Research Use Only (RUO)

Target:

CD38

Clone:

n/a

Size:

ichorbio’s Daratumumab Biosimilar - Research Grade is available in the following sizes: 0.1mg, 5mg, 10mg, 20mg, 50mg, 100mg

Isotype:

Human IgG1 kappa

Other names:

ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 , ADPRC 1, cADPr hydrolase 1

Uniprot:

P56528

Host:

Humanised

Species Reactivity:

Human

Specificity:

Detects human CD38.

Purification Method:

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Antigen Distribution:

Background:

Daratumumab biosimilar is an immunoglobulin G1 kappa (IgG1κ) human monoclonal antibody against CD38 antigen, produced in a mammalian cell line (Chinese Hamster Ovary [CHO]) using recombinant DNA technology. The molecular weight of daratumumab is approximately 148 kDa.

Immunogen:

Concentration:

5mg/ml

Formulation:

Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.

Purity:

>95% by SDS-PAGE and HPLC

Endotoxin:

≤ 1.0 EU/mg as determined by the LAL method

Storage:

Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.

Use:

Products are for research use only.

Isotype Control:

Bulk Human IgG1 Isotype Control (IB1) [ICH2254]